Skip to main content Skip to main navigation Skip to search Skip to footer

Solutions for the Pharmaceutical Industry

The pharmaceutical industry is in its next phase of transformation. Margin pressures, patent cliffs, the rise of emerging markets, and regulatory hurdles are some of its main challenges. Companies can survive and thrive only if they adopt highly differentiated and innovative strategies.

HCL’s solutions help pharmaceutical companies discover opportunities to transform their operations and increase their agility. These include

  • Clinical transformation: HCL draws on extensive experience and expertise in strategy, implementation, and product support across the industry’s R&D value chain. The solutions provided under this category are Data Interchange as a Service (DiaaS), Unified Clinical Platform (UCP), Risk-Based Monitoring solution (rHorizon), Drug Safety Utility Platform (DSUP) and CDISC Conversion Platform. Read more.

  • Commercial transformation: HCL is collaborating with leading pharma and biotech companies, product vendors, and partners to develop consulting frameworks, reference architectures and data models that enable end-to-end transformation of the commercial organization in the pharma industry. This solution has 3 components – namely, Commercial Health Care Analytics, Commercial Operations and Commercial IT. Read more.

  • Manufacturing and supply chain: HCL provides software solutions for improving operational efficiency and for managing regulatory compliance in production environments. Under this category, HCL provides Serialization, E BPR, Demand Dashboards, Risk Based Validation and Track & Trace solutions. Read more.

  • Mobility:HCL has developed robust, scalable, and user-friendly mobile applications on multiple platforms such as Blackberry, Apple, and Android, thereby improving customer engagement and accessibility. Read more.

  • Regulatory affairs and compliance: HCL’s Office of Regulatory Affairs and Compliance includes industry leaders who have an excellent understanding of GxP requirements for the entire pharmaceutical product life cycle. Our Life Sciences Quality Management System (LSQMS) solution is integral to every engagement in the pharmaceutical domain. Read more.

  • ALT ASM™: HCL’s alternative to traditional ASM services helps pharma organizations remain incident free through an exhaustive array of domain-specific tools, dashboards, mobility solutions, plug-ins, and solution accelerators. Read more.

  • Pharmacovigilance: HCL provides a maintenance and support solution, KPO and help-desk solution, validation solution and Argus solution based on implementation, ASM, system validation, case processing, and aggregate reporting services. Read more

  • Lab Informatics Solutions: Aids in cycle-time improvements, resource allocation, and workload monitoring and data accuracy. It assists companies move toward paperless laboratories and ensures successful application/ data migration across platforms, with lab data analytics and lab data and application validation services. It also includes solutions for laboratory technology infrastructure setups, business strategy, laboratory informatics strategy, data migration, data warehousing, lab informatics implementation, laboratory process improvement, Data Migration Integrating and Reporting (DMIR), and Lab Information Management Systems (LabIMS). Read more

  • Information Management: HCL provides reference data management, BDL&A data management, and adaptive multi-channel marketing and decision solutions. Read more

  • Data Integration as a Service: HCL’s platform facilitates the on boarding of contract research organizations (CROs) and the exchange of operational and patient data between sponsors and CROs according to the sponsors. Read more

  • Integrated Platform as a Service: A cloud-based multi-tenant integrated technology platform for biopharmaceutical drug development, offered as an industry solution with a broad set of clinical, safety, and regulatory applications, and scalable computing, storage, database, and analytical capabilities. Read more

  • RWE Data Analytics: HCL’s RWE encompasses CER (payer data) contrasted with the bio-statistical analysis of adaptive trial data (against randomized trials). Read more

  • Enterprise transformation: This new business line enables pharmaceutical organizations to develop a transformational road map and an execution plan. Read more

For more information, write to us at: contact.lsh@hcl.com

Site Section: